Rangwala Reshma sold KPTI
April 21, 2026 · Form 4 insider transaction
Rangwala Reshma sold 449 shares of Karyopharm Therapeutics Inc. at $8.94 per share, a transaction worth $4.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
449
Price
$8.94
Total value
$4.0K
InsiderRangwala Reshma
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateApril 21, 2026
Filing dateApril 22, 2026
Shares owned after56,290
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on April 4, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.